Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$5.63 - $8.27 $54,475 - $80,020
-9,676 Reduced 29.99%
22,584 $152,000
Q3 2023

Nov 13, 2023

BUY
$6.71 - $11.83 $68,408 - $120,606
10,195 Added 46.2%
32,260 $216,000
Q2 2023

Aug 04, 2023

SELL
$11.12 - $22.2 $11,776 - $23,509
-1,059 Reduced 4.58%
22,065 $252,000
Q1 2023

May 11, 2023

SELL
$18.7 - $23.07 $8,078 - $9,966
-432 Reduced 1.83%
23,124 $465,000
Q4 2022

Feb 07, 2023

SELL
$18.12 - $27.32 $311,066 - $469,002
-17,167 Reduced 42.16%
23,556 $534,000
Q3 2022

Nov 10, 2022

SELL
$16.98 - $25.54 $266,127 - $400,288
-15,673 Reduced 27.79%
40,723 $764,000
Q2 2022

Aug 03, 2022

SELL
$13.15 - $20.45 $51,784 - $80,532
-3,938 Reduced 6.53%
56,396 $1.05 Million
Q1 2022

May 04, 2022

BUY
$14.54 - $21.5 $123,284 - $182,298
8,479 Added 16.35%
60,334 $1.09 Million
Q4 2021

Feb 04, 2022

SELL
$20.24 - $36.01 $140,263 - $249,549
-6,930 Reduced 11.79%
51,855 $1.08 Million
Q3 2021

Oct 07, 2021

BUY
$26.01 - $38.22 $65,207 - $95,817
2,507 Added 4.45%
58,785 $1.88 Million
Q2 2021

Aug 04, 2021

SELL
$29.97 - $37.17 $221,867 - $275,169
-7,403 Reduced 11.63%
56,278 $1.73 Million
Q1 2021

May 04, 2021

SELL
$29.24 - $42.03 $390,792 - $561,730
-13,365 Reduced 17.35%
63,681 $2.15 Million
Q4 2020

Feb 02, 2021

BUY
$35.35 - $50.67 $240,097 - $344,150
6,792 Added 9.67%
77,046 $2.78 Million
Q3 2020

Oct 09, 2020

BUY
$35.98 - $47.66 $473,784 - $627,586
13,168 Added 23.07%
70,254 $2.59 Million
Q2 2020

Jul 08, 2020

BUY
$45.06 - $67.74 $1.36 Million - $2.05 Million
30,287 Added 113.02%
57,086 $2.57 Million
Q1 2020

Apr 23, 2020

BUY
$40.01 - $73.97 $106,306 - $196,538
2,657 Added 11.01%
26,799 $1.27 Million
Q4 2019

Feb 11, 2020

BUY
$37.13 - $74.62 $67,687 - $136,032
1,823 Added 8.17%
24,142 $1.73 Million
Q3 2019

Oct 17, 2019

SELL
$39.36 - $76.8 $30,385 - $59,289
-772 Reduced 3.34%
22,319 $878,000
Q2 2019

Aug 02, 2019

SELL
$52.76 - $82.19 $162,342 - $252,898
-3,077 Reduced 11.76%
23,091 $1.81 Million
Q1 2019

May 10, 2019

SELL
$27.39 - $68.41 $15,557 - $38,856
-568 Reduced 2.12%
26,168 $1.56 Million
Q4 2018

Feb 13, 2019

BUY
$22.8 - $33.93 $609,580 - $907,152
26,736 New
26,736 $771,000
Q3 2018

Nov 14, 2018

SELL
$29.75 - $43.08 $10,710 - $15,508
-360 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$17.1 - $26.61 $5,215 - $8,116
-305 Reduced 45.86%
360 $8,000
Q4 2017

Feb 20, 2018

SELL
$9.47 - $19.59 $170 - $352
-18 Reduced 2.64%
665 $13,000
Q2 2017

Aug 14, 2017

BUY
N/A
683
683 $5,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.